(CRM) Salesforce.com - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US79466L3024
Stock: CRM, Platform, Analytics, Commerce, Service
Total Rating 43
Risk 82
Buy Signal 0.23
| Risk 5d forecast | |
|---|---|
| Volatility | 37.4% |
| Relative Tail Risk | -9.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.99 |
| Alpha | -53.36 |
| Character TTM | |
|---|---|
| Beta | 1.286 |
| Beta Downside | 0.972 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.20% |
| CAGR/Max DD | 0.09 |
EPS (Earnings per Share)
Revenue
Description: CRM Salesforce.com March 01, 2026
Salesforce (NYSE: CRM) delivers a comprehensive suite of cloud-based CRM solutions, ranging from the Agentforce AI layer and Data Cloud engine to Slack, Tableau, and industry-specific AI agents. Its portfolio also includes Salesforce Starter for SMBs, commerce services, and field-service tools that unify sales, service, and marketing workflows on a single platform.
In FY 2025 the company posted $31.4 billion in revenue, a 12% year-over-year increase, with subscription-and-support revenue reaching $27.1 billion and operating cash flow of $6.2 billion. Adoption of its Data Cloud and AI-driven features grew roughly 45% YoY, reflecting broader enterprise spending on AI-enabled software, which the IDC forecasts will expand at a 9% annual rate through 2027.
For a deeper dive, you might explore ValueRay’s analyst notes on CRM.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 7.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.74 > 1.0 |
| NWC/Revenue: -21.42% < 20% (prev 4.61%; Δ -26.03% < -1%) |
| CFO/TA 0.13 > 3% & CFO 15.00b > Net Income 7.46b |
| Net Debt (-590.0m) to EBITDA (12.72b): -0.05 < 3 |
| Current Ratio: 0.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (940.0m) vs 12m ago -3.49% < -2% |
| Gross Margin: 77.68% > 18% (prev 0.77%; Δ 7690 % > 0.5%) |
| Asset Turnover: 38.59% > 50% (prev 36.82%; Δ 1.77% > 0%) |
| Interest Coverage Ratio: 45.02 > 6 (EBITDA TTM 12.72b / Interest Expense TTM 202.0m) |
Altman Z'' 1.14
| A: -0.08 (Total Current Assets 28.22b - Total Current Liabilities 37.12b) / Total Assets 112.31b |
| B: 0.20 (Retained Earnings 22.22b / Total Assets 112.31b) |
| C: 0.08 (EBIT TTM 9.09b / Avg Total Assets 107.62b) |
| D: 0.42 (Book Value of Equity 22.54b / Total Liabilities 53.16b) |
| Altman-Z'' Score: 1.14 = BB |
Beneish M -2.91
| DSRI: 1.10 (Receivables 14.34b/11.95b, Revenue 41.52b/37.90b) |
| GMI: 0.99 (GM 77.68% / 77.19%) |
| AQI: 1.07 (AQ_t 0.70 / AQ_t-1 0.66) |
| SGI: 1.10 (Revenue 41.52b / 37.90b) |
| TATA: -0.07 (NI 7.46b - CFO 15.00b) / TA 112.31b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of CRM shares?
As of March 06, 2026, the stock is trading at USD 201.39 with a total of 15,843,090 shares traded.
Over the past week, the price has changed by +0.96%, over one month by +6.01%, over three months by -22.59% and over the past year by -30.57%.
Over the past week, the price has changed by +0.96%, over one month by +6.01%, over three months by -22.59% and over the past year by -30.57%.
Is CRM a buy, sell or hold?
Salesforce.com has received a consensus analysts rating of 4.22.
Therefore, it is recommended to buy CRM.
- StrongBuy: 28
- Buy: 13
- Hold: 12
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the CRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 277.2 | 37.6% |
| Analysts Target Price | 277.2 | 37.6% |
CRM Fundamental Data Overview March 06, 2026
P/E Trailing = 25.7784
P/E Forward = 14.9031
P/S = 4.4265
P/B = 3.0606
P/EG = 0.926
Revenue TTM = 41.52b USD
EBIT TTM = 9.09b USD
EBITDA TTM = 12.72b USD
Long Term Debt = 8.44b USD (from longTermDebt, two quarters ago)
Short Term Debt = 4.55b USD (from shortTermDebt, last quarter)
Debt = 6.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -590.0m USD (from netDebt column, last quarter)
Enterprise Value = 180.98b USD (183.81b + Debt 6.74b - CCE 9.56b)
Interest Coverage Ratio = 45.02 (Ebit TTM 9.09b / Interest Expense TTM 202.0m)
EV/FCF = 12.57x (Enterprise Value 180.98b / FCF TTM 14.40b)
FCF Yield = 7.96% (FCF TTM 14.40b / Enterprise Value 180.98b)
FCF Margin = 34.68% (FCF TTM 14.40b / Revenue TTM 41.52b)
Net Margin = 17.96% (Net Income TTM 7.46b / Revenue TTM 41.52b)
Gross Margin = 77.68% ((Revenue TTM 41.52b - Cost of Revenue TTM 9.27b) / Revenue TTM)
Gross Margin QoQ = 77.61% (prev 78.02%)
Tobins Q-Ratio = 1.61 (Enterprise Value 180.98b / Total Assets 112.31b)
Interest Expense / Debt = 0.99% (Interest Expense 67.0m / Debt 6.74b)
Taxrate = 26.07% (685.0m / 2.63b)
NOPAT = 6.72b (EBIT 9.09b * (1 - 26.07%))
Current Ratio = 0.76 (Total Current Assets 28.22b / Total Current Liabilities 37.12b)
Debt / Equity = 0.11 (Debt 6.74b / totalStockholderEquity, last quarter 59.14b)
Debt / EBITDA = -0.05 (Net Debt -590.0m / EBITDA 12.72b)
Debt / FCF = -0.04 (Net Debt -590.0m / FCF TTM 14.40b)
Total Stockholder Equity = 60.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.93% (Net Income 7.46b / Total Assets 112.31b)
RoE = 12.37% (Net Income TTM 7.46b / Total Stockholder Equity 60.29b)
RoCE = 13.23% (EBIT 9.09b / Capital Employed (Equity 60.29b + L.T.Debt 8.44b))
RoIC = 9.73% (NOPAT 6.72b / Invested Capital 69.11b)
WACC = 10.30% (E(183.81b)/V(190.55b) * Re(10.65%) + D(6.74b)/V(190.55b) * Rd(0.99%) * (1-Tc(0.26)))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.81%
[DCF] Terminal Value 74.16% ; FCFF base≈13.61b ; Y1≈16.79b ; Y5≈28.60b
[DCF] Fair Price = 351.2 (EV 328.52b - Net Debt -590.0m = Equity 329.11b / Shares 937.0m; r=10.30% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 89.47 | EPS CAGR: 43.63% | SUE: 4.0 | # QB: 3
Revenue Correlation: 98.37 | Revenue CAGR: 11.64% | SUE: 0.56 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.12 | Chg7d=+0.117 | Chg30d=+0.116 | Revisions Net=+21 | Analysts=39
EPS current Year (2027-01-31): EPS=13.17 | Chg7d=+0.045 | Chg30d=+0.045 | Revisions Net=+7 | Growth EPS=+5.2% | Growth Revenue=+11.0%
EPS next Year (2028-01-31): EPS=14.90 | Chg7d=-0.031 | Chg30d=-0.081 | Revisions Net=-2 | Growth EPS=+13.2% | Growth Revenue=+9.5%
[Analyst] Revisions Ratio: +0.84 (23 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 10.7% - Earnings Yield 3.9%)
[Growth] Growth Spread = +5.7% (Analyst 12.5% - Implied 6.8%)
P/E Forward = 14.9031
P/S = 4.4265
P/B = 3.0606
P/EG = 0.926
Revenue TTM = 41.52b USD
EBIT TTM = 9.09b USD
EBITDA TTM = 12.72b USD
Long Term Debt = 8.44b USD (from longTermDebt, two quarters ago)
Short Term Debt = 4.55b USD (from shortTermDebt, last quarter)
Debt = 6.74b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -590.0m USD (from netDebt column, last quarter)
Enterprise Value = 180.98b USD (183.81b + Debt 6.74b - CCE 9.56b)
Interest Coverage Ratio = 45.02 (Ebit TTM 9.09b / Interest Expense TTM 202.0m)
EV/FCF = 12.57x (Enterprise Value 180.98b / FCF TTM 14.40b)
FCF Yield = 7.96% (FCF TTM 14.40b / Enterprise Value 180.98b)
FCF Margin = 34.68% (FCF TTM 14.40b / Revenue TTM 41.52b)
Net Margin = 17.96% (Net Income TTM 7.46b / Revenue TTM 41.52b)
Gross Margin = 77.68% ((Revenue TTM 41.52b - Cost of Revenue TTM 9.27b) / Revenue TTM)
Gross Margin QoQ = 77.61% (prev 78.02%)
Tobins Q-Ratio = 1.61 (Enterprise Value 180.98b / Total Assets 112.31b)
Interest Expense / Debt = 0.99% (Interest Expense 67.0m / Debt 6.74b)
Taxrate = 26.07% (685.0m / 2.63b)
NOPAT = 6.72b (EBIT 9.09b * (1 - 26.07%))
Current Ratio = 0.76 (Total Current Assets 28.22b / Total Current Liabilities 37.12b)
Debt / Equity = 0.11 (Debt 6.74b / totalStockholderEquity, last quarter 59.14b)
Debt / EBITDA = -0.05 (Net Debt -590.0m / EBITDA 12.72b)
Debt / FCF = -0.04 (Net Debt -590.0m / FCF TTM 14.40b)
Total Stockholder Equity = 60.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.93% (Net Income 7.46b / Total Assets 112.31b)
RoE = 12.37% (Net Income TTM 7.46b / Total Stockholder Equity 60.29b)
RoCE = 13.23% (EBIT 9.09b / Capital Employed (Equity 60.29b + L.T.Debt 8.44b))
RoIC = 9.73% (NOPAT 6.72b / Invested Capital 69.11b)
WACC = 10.30% (E(183.81b)/V(190.55b) * Re(10.65%) + D(6.74b)/V(190.55b) * Rd(0.99%) * (1-Tc(0.26)))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.81%
[DCF] Terminal Value 74.16% ; FCFF base≈13.61b ; Y1≈16.79b ; Y5≈28.60b
[DCF] Fair Price = 351.2 (EV 328.52b - Net Debt -590.0m = Equity 329.11b / Shares 937.0m; r=10.30% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 89.47 | EPS CAGR: 43.63% | SUE: 4.0 | # QB: 3
Revenue Correlation: 98.37 | Revenue CAGR: 11.64% | SUE: 0.56 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.12 | Chg7d=+0.117 | Chg30d=+0.116 | Revisions Net=+21 | Analysts=39
EPS current Year (2027-01-31): EPS=13.17 | Chg7d=+0.045 | Chg30d=+0.045 | Revisions Net=+7 | Growth EPS=+5.2% | Growth Revenue=+11.0%
EPS next Year (2028-01-31): EPS=14.90 | Chg7d=-0.031 | Chg30d=-0.081 | Revisions Net=-2 | Growth EPS=+13.2% | Growth Revenue=+9.5%
[Analyst] Revisions Ratio: +0.84 (23 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 10.7% - Earnings Yield 3.9%)
[Growth] Growth Spread = +5.7% (Analyst 12.5% - Implied 6.8%)